Guest: Mohamad Bydon, M.D.

Host: Jeffrey S. Brault, D.O. (@JeffBrault)

Dr. Mohamad Bydon discusses harnessing autologous, adipose-derived, mesenchymal stem cells to treat blunt traumatic spinal cord injuries. He details how the the ground-breaking clinical trial is setup, the safety and efficacy goals of the current study, and what they hope to do in phase two.

Connect with the Mayo Clinic’s PM&R Department on Twitter @MayoClinicPMR.

Deeper Dive:

• CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue–Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury: https://doi.org/10.1016/j.mayocp.2019.10.008
• To learn more about Mayo Clinic’s Neuroinformatics Lab visit here: https://www.mayo.edu/research/labs/neuro-informatics/about
• For inquiries regarding the study email: neuroinformatics@mayo.edu